Tag: oncology company

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its second quarter 2025 operating and financial results and reviewed recent business highlights.

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 –

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsOncology company

NING Service Experience Centers Launch in Shanghai and Bangkok, Setting a New Benchmark for the NEV Aftermarket

NING Service Experience Centers Launch in Shanghai and Bangkok, Setting a New Benchmark for the NEV Aftermarket

NING Service Experience Centers Launch in Shanghai and Bangkok, Setting a New Benchmark for the NEV Aftermarket

Tag: oncology company

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us